Literature DB >> 1803989

Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution.

M L Grayson1, G M Eliopoulos, C B Wennersten, K L Ruoff, P C De Girolami, M J Ferraro, R C Moellering.   

Abstract

To identify any change in the antibiotic resistance of Enterococcus faecium, we examined the antibiotic susceptibilities of clinical strains (n = 84) isolated at one institution during the 22 years since 1968. A significant increase in resistance to penicillin was observed during the study period: the MICs of penicillin for 50 and 90% of isolates tested were 16 and 64 micrograms/ml, respectively, from 1969 to 1988 (n = 48; geometric mean MIC, 14 micrograms/ml) , whereas they were 256 and 512 micrograms/ml, respectively, from 1989 to 1990 (n = 36; geometric mean MIC, 123 micrograms/ml) (P less than 0.001). A comparable increase in resistance to ampicillin was also noted (P less than 0.001). No strains produced detectable beta-lactamase. In contrast, susceptibilities to vancomycin, teicoplanin, and ciprofloxacin remained stable. High-level resistance to gentamicin was observed in none of 48 isolates from 1969 to 1988, but was present in 22 of 36 strains (61%) from 1989 to 1990 (P less than 0.001) and was significantly associated with resistance (MIC, greater than or equal to 128 micrograms/ml) to penicillin (P less than 0.001). To assess the potential evolution of antibiotic resistance in this species, clinical isolates (n = 24) were compared with strains isolated in 1968 from a human population in the Solomon Islands that was never exposed to antibiotics. Solomon Island isolates were significantly more susceptible than all clinical strains to penicillin, ampicillin, and vancomycin (P less than 0.001 for each), but they exhibited no differences in susceptibility to teicoplanin or ciprofloxacin. The penicillin-binding affinity of penicillin-binding protein 5 (PBP 5) in penicillin-resistant clinical strains (MIC, 512 micrograms/ml) was notably lower than that in strains with more typical susceptibilities, suggesting an alteration in this PBP as a possible mechanism for increased penicillin resistance. Solomon Island strains most susceptible to penicillin demonstrated a prominent PBP 5* and the absence of PBP 5. These changes in the antibiotic resistance of E. faecium emphasize the importance of identifying this species in patients with serious enterococcal infections and the necessity of assessing its susceptibility to both beta-lactams and aminoglycosides if effective therapy is to be identified.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1803989      PMCID: PMC245356          DOI: 10.1128/AAC.35.11.2180

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Enterococci from blood cultures during 1980-1989: susceptibility to ampicillin, penicillin and vancomycin.

Authors:  C Watanakunakorn
Journal:  J Antimicrob Chemother       Date:  1990-10       Impact factor: 5.790

Review 2.  Resistance of enterococci to glycopeptides.

Authors:  P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

3.  Identification of Enterococcus species isolated from human infections by a conventional test scheme.

Authors:  R R Facklam; M D Collins
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

4.  Use of penicillin-binding proteins for the identification of enterococci.

Authors:  R Williamson; L Gutmann; T Horaud; F Delbos; J F Acar
Journal:  J Gen Microbiol       Date:  1986-07

5.  Recovery of resistance (R) factors from a drug-free community.

Authors:  P Gardner; D H Smith; H Beer; R C Moellering
Journal:  Lancet       Date:  1969-10-11       Impact factor: 79.321

6.  Penicillin-binding proteins of multiply antibiotic-resistant South African strains of Streptococcus pneumoniae.

Authors:  S Zighelboim; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

7.  Identification of a streptococcal penicillin-binding protein that reacts very slowly with penicillin.

Authors:  R Fontana; R Cerini; P Longoni; A Grossato; P Canepari
Journal:  J Bacteriol       Date:  1983-09       Impact factor: 3.490

8.  Ampicillin-resistant enterococcal species in an acute-care hospital.

Authors:  S E Oster; V A Chirurgi; A A Goldberg; S Aiken; R E McCabe
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

9.  High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections.

Authors:  L M Bush; J Calmon; C L Cherney; M Wendeler; P Pitsakis; J Poupard; M E Levison; C C Johnson
Journal:  Ann Intern Med       Date:  1989-04-01       Impact factor: 25.391

10.  Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem?

Authors:  F L Sapico; H N Canawati; V J Ginunas; D S Gilmore; J Z Montgomerie; W J Tuddenham; R R Facklam
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

View more
  60 in total

Review 1.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Influence of high-level gentamicin resistance and beta-hemolysis on susceptibility of enterococci to the bactericidal activities of ampicillin and vancomycin.

Authors:  E Cercenado; G M Eliopoulos; C B Wennersten; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

Review 3.  Beta-lactamase-producing enterococci.

Authors:  B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

4.  Enterococci: on the back burner but still simmering.

Authors:  George M Eliopoulos
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

5.  Enterococcus faecium low-affinity pbp5 is a transferable determinant.

Authors:  Louis B Rice; Lenore L Carias; Susan Rudin; Viera Lakticová; Aaron Wood; Rebecca Hutton-Thomas
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 6.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

7.  Genetic linkage and cotransfer of a novel, vanB-containing transposon (Tn5382) and a low-affinity penicillin-binding protein 5 gene in a clinical vancomycin-resistant Enterococcus faecium isolate.

Authors:  L L Carias; S D Rudin; C J Donskey; L B Rice
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

8.  Synergy and resistance to synergy between beta-lactam antibiotics and glycopeptides against glycopeptide-resistant strains of Enterococcus faecium.

Authors:  L Gutmann; S al-Obeid; D Billot-Klein; M L Guerrier; E Collatz
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Reliability of the E test for detection of ampicillin, vancomycin, and high-level aminoglycoside resistance in Enterococcus spp.

Authors:  J E Schulz; D F Sahm
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

10.  Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium.

Authors:  N Mobarakai; J M Quale; D Landman
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.